🔍 Definition
Encephalopathy is a broad term for any diffuse brain dysfunction characterized by altered mental status, cognitive impairment, or changes in consciousness — caused by an underlying systemic, metabolic, toxic, or structural disorder. The term encompasses a spectrum from mild confusion to deep coma, and its etiology determines both the correct ICD-10-CM code and the clinical management approach.
Delirium (ICD-10-CM F05) is a specific neuropsychiatric syndrome characterized by an acute onset of fluctuating disturbance in attention, awareness, and cognition — not attributable to a pre-existing or evolving neurocognitive disorder, and not explained by a severely reduced level of arousal. Delirium is acute, reversible in most cases, and multifactorial, but a single etiology (e.g., medications, infection, metabolic derangement) often predominates.
For clinical documentation and coding purposes, the distinction between encephalopathy subtypes is critical: CMS ICD-10-CM FY2027 assigns different codes — and different MS-DRG weight impacts — depending on whether the condition is metabolic, toxic, anoxic, hepatic, uremic, hypertensive, PRES-related, or substance-induced. A non-specific “altered mental status” (R41.0) carries no CC/MCC, while documented metabolic encephalopathy (G93.41) triggers MCC status in most DRGs.
“Altered mental status” coded to R41.0 carries no CC or MCC weight. “Metabolic encephalopathy” coded to G93.41 is an MCC, capable of shifting MS-DRG reimbursement by thousands of dollars per case (e.g., simple pneumonia DRG 195 → complex DRG 193). Ensure that when the clinical picture supports encephalopathy, the physician documents the specific type and etiology — not just “AMS” or “confusion.”
🗂️ Alternative Terminology
The following table maps commonly used clinical terms to their formal ICD-10-CM equivalents. Coders and CDI specialists should recognize all variants in physician documentation and query accordingly.
| Formal / ICD-10-CM Term | Common Clinical / Lay Terms |
|---|---|
| Metabolic encephalopathy (G93.41) | Metabolic brain syndrome, ICU encephalopathy, critical illness encephalopathy, septic encephalopathy (with A41.x), uremic encephalopathy (with N18.x) |
| Toxic encephalopathy (G92.8, G92.9; ICANS reported with G92.00–G92.05 by grade) | Drug-induced encephalopathy, medication neurotoxicity, toxic-metabolic brain disorder, chemotherapy brain |
| Anoxic brain damage (G93.1) | Hypoxic encephalopathy, hypoxic-ischemic encephalopathy (HIE), post-cardiac arrest encephalopathy, anoxic injury |
| Hypertensive encephalopathy (I67.4); posterior reversible encephalopathy syndrome (PRES) (I67.83) | Hypertensive crisis with brain involvement, malignant hypertension with encephalopathy; PRES when specifically documented |
| Hepatic encephalopathy (K76.82 without coma; applicable hepatic failure with coma code when coma is documented) | Portosystemic encephalopathy, hepatocerebral intoxication, hepatic coma, liver failure with brain dysfunction, HE, portosystemic shunt encephalopathy |
| Wernicke’s encephalopathy (E51.2) | Thiamine deficiency encephalopathy, Wernicke-Korsakoff syndrome (acute phase), alcoholic encephalopathy (nutritional) |
| Delirium (F05) | ICU psychosis, acute confusional state, acute organic brain syndrome, hospital delirium, sundowning (when acute) |
| Alcohol withdrawal delirium (F10.231) | Delirium tremens (DTs), alcohol withdrawal with delirium |
| Altered mental status (R41.0) | AMS, confusion, change in mental status, obtundation, clouded consciousness (non-specific, use only when encephalopathy not confirmed) |
The term “sundowning” is not an ICD-10-CM code. When used in documentation for an acute inpatient stay, query for whether the presentation meets criteria for delirium (F05) vs. a behavioral disturbance of dementia (F0x.xx). The distinction has significant coding and DRG implications.
🩺 Signs & Symptoms
Recognizing the clinical presentation is essential for CDI specialists to identify query opportunities before physician attestation is secured. The following manifestations, when documented without an underlying confirmed diagnosis, represent prime query triggers.
| Domain | Clinical Manifestation | CDI Significance |
|---|---|---|
| Cognitive | Disorientation to time/place/person, confusion, memory impairment, inability to follow commands | Differentiates delirium from dementia; acute onset supports delirium/encephalopathy |
| Attention | Inattention, distractibility, inability to maintain focus, fluctuating alertness | Core diagnostic criterion for delirium (DSM-5); document acuity and onset |
| Level of Consciousness | Somnolence, lethargy, obtundation, stupor, coma | Severity staging supports MCC coding; document GCS score |
| Behavior | Agitation, restlessness, combativeness (hyperactive delirium); withdrawal, psychomotor slowing (hypoactive delirium) | Hypoactive delirium often missed; both subtypes code to F05 |
| Perceptual | Hallucinations (visual most common in delirium), illusions, paranoia | Visual hallucinations support delirium; auditory more common in psychiatric disorders |
| Sleep-Wake | Day-night reversal, fragmented sleep, insomnia | Supports delirium when acute; distinguish from chronic sleep disorder |
| Neurological | Asterixis (flapping tremor), myoclonus, dysarthria, ataxia, seizures | Asterixis strongly associated with metabolic/hepatic encephalopathy; document explicitly |
| Autonomic | Tachycardia, diaphoresis, hypertension, fever (in withdrawal) | Autonomic instability hallmark of alcohol withdrawal delirium (DTs) — critical for F10.231 |
🧭 Differential Diagnosis
A rigorous differential is the foundation of accurate documentation. The CDI specialist’s role is to ensure the physician has documented to the appropriate level of specificity — not just “encephalopathy” but the etiological subtype, and not just “delirium” but whether it is due to a medical condition, substance use, or withdrawal.
| Condition | Key Distinguishing Features | Primary ICD-10-CM Code |
|---|---|---|
| Metabolic encephalopathy | Elevated serum metabolites (ammonia, BUN, glucose, sodium, calcium); precipitant identifiable (sepsis, organ failure, electrolyte disorder) | G93.41 (MCC) |
| Hepatic encephalopathy | Known liver disease, elevated ammonia, asterixis, portal hypertension; use K76.82 for hepatic encephalopathy without coma and code also the underlying liver disease when applicable; use the applicable hepatic failure with coma code instead when coma is documented | K76.82 (without coma); K72.01, K70.41, K72.11, or K72.91 when hepatic failure with coma is documented |
| Toxic encephalopathy | Exposure history (medications, toxins, heavy metals, carbon monoxide); temporal relationship with exposure | G92.8 or G92.9 (MCC); code first poisoning due to drug/toxin when applicable; use G92.00–G92.05 for ICANS by grade |
| Anoxic brain damage | Post-cardiac arrest, prolonged hypoxemia, near-drowning; diffusion-restricted MRI; elevated serum NSE | G93.1 (CC) |
| Hypertensive encephalopathy / PRES | Severe hypertension with encephalopathy may support I67.4 when documented; PRES on MRI is coded separately when documented; exclude stroke | I67.4 (CC) for hypertensive encephalopathy; I67.83 (MCC) for PRES |
| Uremic encephalopathy | Elevated BUN/creatinine; known CKD/ESRD; asterixis; responds to dialysis | N18.x + R41.0 (or G93.41 if physician documents metabolic encephalopathy) |
| Wernicke’s encephalopathy | Classic triad: confusion + ataxia + ophthalmoplegia; alcohol use disorder or malnutrition; thiamine deficiency | E51.2 (CC) |
| Delirium (not elsewhere specified) | Acute, fluctuating; inattention; no identified metabolic/toxic cause; or cause documented separately | F05 (CC in many DRGs) |
| Alcohol withdrawal delirium | Last drink 24–72 hrs prior; autonomic instability; seizure history; CIWA score elevated | F10.231 (MCC) |
| Dementia with behavioral disturbance | Chronic, progressive; pre-existing diagnosis; not acute onset; behavioral symptoms | F0x.xx (various) |
| Psychiatric disorder (new onset psychosis) | Young patient; no metabolic trigger; command hallucinations; thought disorder | F20.x–F29.x |
| Non-convulsive status epilepticus | EEG confirmation; no overt clinical seizure; may mimic delirium or coma | G41.x |
Per ICD-10-CM tabular instructions, hepatic encephalopathy without coma is coded to K76.82, with the underlying liver disease coded as applicable. Do NOT add a G93.4x code for hepatic encephalopathy. When hepatic failure with coma is documented, report the applicable hepatic failure with coma code (for example, K72.01, K70.41, K72.11, or K72.91) instead of K76.82 because K76.82 has Excludes1 notes for those coma codes.
📋 Clinical Indicators
The following clinical indicators, when present in the medical record, represent documentation gaps or query opportunities. CDI specialists should review these indicators during concurrent or retrospective review.
| Clinical Indicator | Documentation Gap | Query Opportunity |
|---|---|---|
| AMS or “confusion” in problem list/assessment | R41.0 — no CC value; physician likely observed encephalopathy | Query for encephalopathy type and etiology |
| Elevated ammonia level (NH3 >50 µmol/L) | May reflect metabolic or hepatic etiology; not coded unless linked to diagnosis | Query if hepatic vs. metabolic encephalopathy; check K72.xx vs. G93.41 |
| Sepsis documented + neurological changes | Septic encephalopathy requires dual coding per AHA CC Q1 2017 | Query for “metabolic encephalopathy due to sepsis” → A41.x + G93.41 |
| ICU admission for neuro monitoring | ICU-level care implies serious neurologic event; diagnoses must reflect severity | Confirm encephalopathy type documented; query if only AMS recorded |
| EEG ordered with diffuse slowing | Non-convulsive seizure vs. encephalopathy vs. metabolic etiology | Query for cause of EEG change and whether encephalopathy diagnosed |
| Thiamine administration in orders | Wernicke’s risk recognized by clinical team but may not be documented | Query for Wernicke’s encephalopathy (E51.2) if classic triad present |
| Acute-on-chronic confusion | Baseline dementia + acute superimposed delirium = dual coding needed | Query for “delirium superimposed on dementia” — both codes apply |
| Alcohol use disorder in H&P + agitation/tremor | Alcohol withdrawal delirium (DTs) is MCC; may be underdocumented | Query for F10.231 if autonomic instability and last-drink timeline present |
| Neurology consult for “encephalopathy” | Consultant documents etiology; primary team may not carry it to final Dx | Query primary physician to co-document etiology specified in consult note |
| Head CT or MRI ordered for altered mental status | Imaging may reveal structural cause (PRES, infarct, hemorrhage) | Query for imaging-confirmed diagnosis if radiologist describes encephalopathy pattern |
🦴 Anatomy & Pathophysiology
Understanding the underlying pathophysiology of encephalopathy and delirium enables CDI specialists to recognize when clinical findings are consistent with physician documentation — and when a query is warranted.
Normal Brain Function: The cerebral cortex and reticular activating system (RAS) maintain arousal, attention, and cognition through neurotransmitter balance (acetylcholine, dopamine, GABA, glutamate). The blood-brain barrier (BBB) protects neural tissue from systemic toxins.
Metabolic Encephalopathy Mechanism: Systemic metabolic derangements — elevated ammonia, uremic toxins, hyperglycemia/hypoglycemia, hypoxia, hypercapnia, electrolyte disturbances — penetrate or disrupt the BBB, impairing neuronal energy metabolism and neurotransmitter synthesis. Acetylcholine deficiency is a common final pathway, consistent with the inattention and cognitive impairment of delirium. Per UpToDate, the cholinergic hypothesis is supported by the propensity of anticholinergic medications to precipitate delirium.
Hepatic Encephalopathy: In liver failure, ammonia — normally metabolized by the urea cycle — accumulates in the systemic circulation. Ammonia crosses the BBB and is converted to glutamine in astrocytes, causing astrocyte swelling (osmotic effect) and neuronal excitotoxicity. Inflammatory cytokines from gut-derived infection synergize with ammonia to worsen encephalopathy. The American Association for the Study of Liver Diseases (AASLD) staging (West Haven criteria: Grade 0–IV) supports documentation of encephalopathy severity; ICD-10-CM coding distinguishes hepatic encephalopathy without coma (K76.82) from hepatic failure with coma codes such as K72.01, K72.11, and K72.91.
Toxic Encephalopathy: Exogenous neurotoxins — medications (opioids, benzodiazepines, anticholinergics, immunosuppressants), industrial chemicals, heavy metals — directly impair neuronal function. Polypharmacy is a major risk factor, particularly in elderly patients. The mechanism varies: receptor blockade, ion channel disruption, mitochondrial dysfunction, or direct cytotoxicity.
Anoxic Brain Damage (G93.1): Global cerebral ischemia (cardiac arrest, asphyxia) depletes neuronal ATP within 4–6 minutes, triggering glutamate-mediated excitotoxicity, calcium influx, and apoptotic cascades. Neurological injury severity correlates with duration of anoxia and is assessed by Cerebral Performance Category (CPC) scale and EEG pattern.
Wernicke’s Encephalopathy (E51.2): Thiamine (vitamin B1) deficiency impairs the pyruvate dehydrogenase complex and transketolase enzymes, disrupting glucose metabolism in the thalamus, mammillary bodies, and brainstem. NINDS notes that without prompt thiamine replacement, the acute Wernicke’s phase can progress to permanent Korsakoff amnestic syndrome.
💊 Medication Impact / Treatment
Medications play a dual role in encephalopathy and delirium: they are among the most common precipitants, and they are also the cornerstone of targeted treatment. Documentation of medication-related causality is critical for both accurate coding and CDI query development.
Medications That Precipitate or Worsen Encephalopathy/Delirium:
- Benzodiazepines: GABA-A agonists — impair attention and arousal; paradoxical agitation in elderly; withdrawal delirium on abrupt cessation. Associated with G92.8 or G92.9 when toxic encephalopathy is documented; code the causative drug/toxin per poisoning or adverse-effect rules.
- Opioids: CNS depression, respiratory acidosis/hypercapnia, constipation (↑ ammonia). Naloxone-reversible. Opioid-induced toxic encephalopathy → G92.8 or G92.9 with T40.- poisoning code when due to overdose/incorrect use, or T40.- adverse-effect code when correctly prescribed and properly administered.
- Anticholinergics: (diphenhydramine, tricyclics, bladder agents, antiemetics) — block central acetylcholine, worsening the cholinergic deficit in delirium. High Anticholinergic Burden (ACB) score correlates with delirium risk.
- Antiepileptics: Valproate, levetiracetam, phenytoin — can cause drug-induced encephalopathy, especially at supratherapeutic levels.
- Steroids: Steroid-induced psychosis/delirium — document as “steroid-induced delirium” → F05 with appropriate T-code for adverse effect.
- Immunosuppressants/Chemotherapy: Tacrolimus, cyclosporine, methotrexate, ifosfamide → toxic encephalopathy (G92.8 or G92.9, with causative-drug T-code as applicable); distinguish from disease-related CNS involvement and from ICANS (G92.00–G92.05).
- Antibiotics: Cefepime (cefepime-induced neurotoxicity), fluoroquinolones, metronidazole — documented toxic encephalopathy → G92.8 or G92.9, with causative antibiotic T-code as applicable.
Therapeutic Agents (Treatment-Focused):
- Thiamine (Vitamin B1 / J3411): First-line and emergent for Wernicke’s encephalopathy. High-dose IV thiamine (500 mg TID IV) per European Federation of Neurological Societies (EFNS) guidelines. HCPCS J3411 (thiamine HCl injection) — critical for Wernicke’s documentation and coding.
- Lactulose: Reduces intestinal ammonia absorption — mainstay of hepatic encephalopathy management (K72.xx). Available Part D; oral/enema formulations. Titrate to 2–3 soft stools/day.
- Rifaximin: Antibiotic reducing gut ammonia-producing bacteria; used as adjunct/secondary prophylaxis in hepatic encephalopathy.
- Haloperidol: Low-dose IV/IM for acute agitation in delirium (evidence-based per SCCM PADIS Guidelines); Part D. Use with caution in alcohol withdrawal (not appropriate monotherapy for DTs).
- Quetiapine / Olanzapine: Second-generation antipsychotics for hyperactive delirium; Part D. Quetiapine commonly used in ICU delirium protocols.
- Dexmedetomidine (Precedex): Alpha-2 agonist; preferred sedation in mechanically ventilated patients to reduce delirium duration per SCCM PADIS Guidelines.
- Midazolam (J2250): Benzodiazepine indicated specifically for alcohol withdrawal delirium/DTs (F10.231); monitor for respiratory depression; not first-line for non-withdrawal delirium.
- IV Acetaminophen (J0131): Non-opioid analgesic alternative to reduce delirium-precipitating opioid burden in postoperative patients.
When a patient on polypharmacy presents with altered mental status, the record may reflect both a metabolic derangement AND high-risk medications. The distinction between medication-induced/toxin-induced encephalopathy (usually G92.8 or G92.9, with causative-drug/toxin coding as applicable) and metabolic encephalopathy (G93.41) from organ dysfunction has DRG and HCC implications. Query the attending for the primary etiology: “Is the patient’s encephalopathy primarily metabolic (organ failure-related), primarily medication/toxin-induced (toxic encephalopathy), or a combination? If combination, which is the predominant mechanism?”
Preview ends here. The full guide continues with FY2027 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.
← Back to All Clinical Documentation Guides
📘 ICD-10-CM Guidelines
The following official coding guidelines from CMS ICD-10-CM FY2027 and NCHS apply to encephalopathy and delirium coding. Adherence is required for compliant coding.
General Coding Principle — Etiology/Manifestation: When encephalopathy is a manifestation of an underlying condition, ICD-10-CM requires sequencing per the etiology/manifestation convention. The underlying condition is sequenced first (e.g., sepsis A41.x, hepatic failure K72.xx, uremia N18.x) with the manifestation coded as additional (e.g., G93.41), unless the tabular includes the manifestation in the code definition (as with K72.xx which includes hepatic encephalopathy).
Septic Encephalopathy: Per AHA Coding Clinic, 2Q 2017, “Encephalopathy due to Sepsis“, encephalopathy documented as due to sepsis (septic encephalopathy) is assigned G93.41, Metabolic encephalopathy. The FY 2027 Index entry Encephalopathy, septic, directs to G93.41, and the R65.2 use additional code note lists encephalopathy (metabolic) (septic) (G93.41) when severe sepsis is present. Code and sequence the sepsis according to Section I.C.1.d, with G93.41 as an additional diagnosis. Signs and symptoms routinely associated with the encephalopathy, such as disorientation (R41.0), are not coded separately (Section I.B.5).
Hepatic Encephalopathy — Do Not Assign G93.4x: ICD-10-CM code K76.82 reports hepatic encephalopathy without coma and includes hepatic encephalopathy NOS, hepatic encephalopathy without coma, hepatocerebral intoxication, and portal-systemic encephalopathy. Code also the underlying liver disease when applicable. Do NOT assign G93.4x for hepatic encephalopathy. When hepatic failure with coma is documented, report the applicable coma code instead (for example, K72.01, K70.41, K72.11, or K72.91), because K76.82 has Excludes1 notes for hepatic failure with coma codes.
Toxic Encephalopathy — Adverse Effect vs. Poisoning: G92.8 and G92.9 require coding the causative substance when applicable. Code first poisoning, drug- or toxin-induced codes (T36–T65 with fifth or sixth character 1–4 or 6) to identify the toxic agent when applicable; for adverse effects of correctly administered drugs, use an additional T36–T50 code with fifth or sixth character 5 to identify the drug. Per ICD-10-CM Official Guidelines Section I.C.19.e, the adverse effect code is sequenced after the condition it caused.
Delirium Coding — F05 vs. Substance-Induced Delirium: F05 (Delirium due to known physiological condition) is used when delirium results from a general medical condition (metabolic, infectious, neurological) that is NOT substance intoxication or withdrawal. When delirium is substance-induced, use the specific F10–F19 code for the substance, pattern of use/abuse/dependence, and clinical state (for example, intoxication with delirium or withdrawal delirium). F10.231 reports alcohol dependence with withdrawal delirium; F10.931 reports alcohol use, unspecified with withdrawal delirium when dependence or abuse is not documented.
Acute vs. Chronic Distinction: Document and code the acuity explicitly. Acute metabolic encephalopathy in an ICU patient differs fundamentally from chronic alcoholic brain degeneration (G31.2). Chronic dementia (F03.x) is not encephalopathy. Co-occurring delirium superimposed on dementia requires both a dementia code (F0x.x) and F05 as additional diagnosis per CMS coding guidance.
Uremic Encephalopathy: There is no single ICD-10-CM code for “uremic encephalopathy.” Code the underlying CKD stage (N18.1–N18.6) and, if the physician documents encephalopathy as a manifestation of uremia, also code G93.41 (metabolic encephalopathy) as an additional diagnosis — confirmed by attending physician documentation. R41.0 (altered mental status) is not used when encephalopathy is confirmed.
Anoxic Brain Damage (G93.1): G93.1 is assigned for anoxic brain damage, not elsewhere classified, such as documented adult post-cardiac arrest anoxic brain injury/encephalopathy when no more specific code applies. It is distinct from hypoxic respiratory failure and from neonatal HIE (P91.60–P91.63). The underlying cause (cardiac arrest, asphyxia) is coded separately. Do not use G93.42 for adult HIE; G93.42 is megalencephalic leukoencephalopathy with subcortical cysts.
Wernicke’s Encephalopathy (E51.2): E51.2 is under category E51 (Thiamine deficiency). The underlying cause — alcohol use disorder, malnutrition, hyperemesis — should also be coded. If alcohol use disorder is present, code it (F10.xx) as an additional diagnosis. Note: E51.11 (Dry beriberi) and E51.12 (Wet beriberi) are distinct from E51.2 and reflect peripheral nerve vs. cardiovascular manifestations of thiamine deficiency, not encephalopathy.
🔢 ICD-10-CM Code Set (Tabular)
All codes verified for FY2027 per CMS ICD-10-CM FY2027 Tabular List and FY 2027 MS-DRG v44 severity designations.
| ICD-10-CM Code | Description | CC/MCC Status | Coding Notes |
|---|---|---|---|
| F05 | Delirium due to known physiological condition | CC | Use for delirium from medical condition (NOT substance-induced). Code underlying condition first (etiology/manifestation). |
| G93.40 | Encephalopathy, unspecified | CC | Use only when type cannot be determined. Query first — avoid this non-specific code when etiology is known. |
| G93.41 | Metabolic encephalopathy | MCC | PRIMARY CDI TARGET. Includes septic encephalopathy (+ A41.x), uremic encephalopathy (+ N18.x), electrolyte-related. Not for hepatic (use K72.xx). |
| G93.42 | Megalencephalic leukoencephalopathy with subcortical cysts | CC | Specific leukodystrophy/white-matter disorder. Do not use for adult post-cardiac arrest HIE; use G93.1 for anoxic brain damage NEC when documented. |
| G93.43 | Leukoencephalopathy with calcifications and cysts | CC | Specific leukoencephalopathy/white-matter disorder; code only when specifically documented. |
| G93.44 | Adult-onset leukodystrophy with axonal spheroids | CC | Specific adult-onset leukodystrophy; code only when specifically documented. |
| G93.45 | Developmental and epileptic encephalopathy | CC | Code also epilepsy by specific type (G40.-), when applicable. |
| G93.43 | Leukoencephalopathy with calcifications and cysts | CC | Specific white-matter disorder; do not default to G93.49 when documented. |
| G93.44 | Adult-onset leukodystrophy with axonal spheroids | CC | Specific adult-onset leukodystrophy; do not default to G93.49 when documented. |
| G93.45 | Developmental and epileptic encephalopathy | CC | Specific developmental/epileptic encephalopathy; code associated epilepsy or genetic condition when documented and supported by the Tabular instructions. |
| G93.49 | Other encephalopathy | CC | Use when encephalopathy documented but does not fit G93.41 or a more specific code. Includes encephalopathy NEC when no more specific Tabular or Index entry applies. |
| G93.1 | Anoxic brain damage, not elsewhere classified | CC | Post-cardiac arrest or other anoxic brain damage NEC; code underlying cause separately (e.g., cardiac arrest I46.9). Do not report G93.42 for adult post-cardiac-arrest HIE. |
| G92.00–G92.05 | Immune effector cell-associated neurotoxicity syndrome, by grade | Non-CC to CC (varies by grade) | CAR-T/immune effector cellular therapy-related neurotoxicity (ICANS). G92.0 is a nonbillable parent code; report the documented grade (G92.00 unspecified, G92.01 grade 1, G92.02 grade 2, G92.03 grade 3, G92.04 grade 4, G92.05 grade 5). Code first the underlying cause, such as complication of immune effector cellular therapy (T80.82-), when applicable. |
| G92.8 | Other toxic encephalopathy | MCC | Drug/medication/chemical-induced encephalopathy. Code causative substance with T-code (adverse effect or poisoning). Includes cefepime neurotoxicity, valproate encephalopathy. |
| G92.9 | Unspecified toxic encephalopathy | MCC | Avoid — query for specific toxic agent. Use only when substance type cannot be determined. |
| G31.2 | Degeneration of nervous system due to alcohol | CC | Chronic alcoholic brain degeneration (Korsakoff’s). Distinct from acute Wernicke’s (E51.2). Code F10.xx additionally. |
| E51.2 | Wernicke’s encephalopathy | CC | Acute thiamine deficiency encephalopathy. Code associated alcohol use disorder (F10.xx) and malnutrition (E40–E46) when documented; do not use R63.0 to report malnutrition. Prompt IV thiamine is clinically important. |
| E51.11 | Dry beriberi | CC | Peripheral neuropathy of thiamine deficiency — NOT encephalopathy. Do not use for Wernicke’s. |
| K76.82 | Hepatic encephalopathy | Non-CC | Use for hepatic encephalopathy without coma; code also the underlying liver disease, when applicable. Do NOT add G93.4x. |
| K72.00 | Acute and subacute hepatic failure without coma | MCC | Use for acute/subacute hepatic failure without coma. Code also K76.82 when hepatic encephalopathy without coma is documented. |
| K72.01 | Acute and subacute hepatic failure with coma | MCC | Use for acute/subacute hepatic failure with coma. Do NOT add G93.4x or K76.82 because K76.82 excludes hepatic failure with coma. |
| K72.10 | Chronic hepatic failure without coma | MCC | Use for chronic hepatic failure without coma. Code also K76.82 when hepatic encephalopathy without coma is documented; do NOT add G93.4x. |
| K72.11 | Chronic hepatic failure with coma | MCC | Use for chronic hepatic failure with coma. Do NOT add G93.4x or K76.82 because K76.82 excludes hepatic failure with coma. |
| K72.90 | Hepatic failure, unspecified, without coma | MCC | Use when hepatic failure acuity is unknown. Query for acute vs. chronic; code also K76.82 when hepatic encephalopathy without coma is documented. |
| K72.91 | Hepatic failure, unspecified, with coma | MCC | Hepatic failure with coma; confirm coma and acuity with the physician. Do NOT add K76.82 because K76.82 excludes hepatic failure with coma. |
| I67.4 | Hypertensive encephalopathy | CC | Hypertensive encephalopathy; code associated hypertensive emergency/urgency and underlying hypertension as documented. |
| I67.83 | Posterior reversible encephalopathy syndrome (PRES) | MCC | Use when PRES is documented. Do not default PRES to I67.4 unless the provider specifically documents hypertensive encephalopathy. |
| F10.231 | Alcohol dependence with withdrawal delirium | MCC | Delirium tremens (DTs). Requires alcohol dependence + withdrawal + delirium documented. Highest severity alcohol withdrawal code. |
| F10.921 | Alcohol use, unspecified, with intoxication delirium | CC | Acute alcohol intoxication with delirium — NOT withdrawal. Distinguish from F10.231. |
| F10–F19 substance-related delirium codes | Substance-induced intoxication or withdrawal delirium | CC–MCC (varies by substance, pattern, and code) | Use the specific substance category and documented pattern (use, abuse, or dependence). Examples include intoxication with delirium codes such as F10.921 and F11.921, dependence/withdrawal delirium codes such as F10.231, and use-unspecified withdrawal delirium codes such as F10.931 when dependence or abuse is not documented. |
| R41.0 | Disorientation, unspecified (Altered mental status) | No CC/MCC | Use ONLY when encephalopathy or specific cognitive disorder is NOT confirmed. Do not use when encephalopathy documented. This is a symptom code only. |
G93.41 metabolic encephalopathy as a secondary diagnosis triggers MCC status in the majority of MS-DRGs, representing a major reimbursement impact. Example DRG shifts:
- Pneumonia: DRG 195 (simple, ~$6,800) → DRG 193 (MCC, ~$14,200) — ~$7,400 difference
- Septicemia: DRG 872 (no MCC, ~$9,100) → DRG 871 (MCC, ~$17,600) — ~$8,500 difference
- UTI: DRG 690 (no CC, ~$4,200) → DRG 689 (MCC, ~$11,500) — ~$7,300 difference
Similarly, HCC v28 impact: G93.40, G93.41, and G93.49 have no V28 payment HCC in the CMS 2027 Initial ICD-10-CM Mappings; HCC 253 is Hemiplegia/Hemiparesis. Documentation of metabolic encephalopathy in an outpatient/annual wellness setting supports accurate RAF capture and appropriate plan funding.
🔎 Indexing
The ICD-10-CM Alphabetical Index provides the following pathways for encephalopathy and delirium. Coders should verify all index lookups against the FY2027 Tabular List for accuracy. Per NCHS ICD-10-CM Index:
| Index Entry | Subterm | Code Assigned |
|---|---|---|
| Encephalopathy | (default/unspecified) | G93.40 |
| Encephalopathy | metabolic | G93.41 |
| Encephalopathy | toxic | G92.8 |
| Encephalopathy | anoxic — see Damage, brain, anoxic | G93.1 |
| Encephalopathy | hepatic, without coma | K76.82 |
| Encephalopathy | hypertensive | I67.4 |
| Encephalopathy | Wernicke’s | E51.2 |
| Encephalopathy | alcoholic (chronic degeneration) | G31.2 |
| Encephalopathy | septic — index to metabolic | G93.41 (+ A41.x sepsis) |
| Delirium | (default, due to known physiological condition) | F05 |
| Delirium | alcohol-induced, with dependence, with withdrawal | F10.231 |
| Delirium | drug-induced — see category F11–F19 with .x21 | F1x.x21 |
| Delirium | tremens (alcohol withdrawal) | F10.231 |
| Status | mental, altered — see Disorientation | R41.0 |
| Disorientation | unspecified | R41.0 |
The FY 2027 ICD-10-CM Alphabetic Index has a subterm for this condition: Encephalopathy, septic, directs to G93.41, Metabolic encephalopathy, and G93.41 lists “Septic encephalopathy” as an inclusion term. AHA Coding Clinic, 2Q 2017, “Encephalopathy due to Sepsis“, assigns G93.41 for encephalopathy due to sepsis. Do not assign G93.40 or G93.49 when the provider documents septic encephalopathy or encephalopathy due to sepsis. Code the sepsis separately according to Section I.C.1.d.
🏥 CPT
The following CPT codes apply to evaluation, management, diagnostic workup, and procedures in encephalopathy and delirium. All listed codes were reviewed for CY2027 against the 2027 CPT change files.
| CPT Code | Description | Global Period | Coding Notes |
|---|---|---|---|
| 99221 | Initial hospital inpatient care, low complexity (30 min MDM or 40 min total time) | N/A | E/M — document MDM or total time; qualify complexity level to code correctly |
| 99222 | Initial hospital inpatient care, moderate complexity (40 min MDM or 55 min total time) | N/A | Most encephalopathy/delirium admissions meet moderate MDM (multiple chronic conditions + acute exacerbation) |
| 99223 | Initial hospital inpatient care, high complexity (60 min MDM or 75 min total time) | N/A | ICU-level care, multiple organ dysfunction — high MDM typically met |
| 99231 | Subsequent hospital inpatient care, low complexity (20 min MDM or 25 min total time) | N/A | Subsequent hospital day E/M — stable, improving patient |
| 99232 | Subsequent hospital inpatient care, moderate complexity (30 min MDM or 35 min total time) | N/A | Most common subsequent code for encephalopathy monitoring |
| 99233 | Subsequent hospital inpatient care, high complexity (40 min MDM or 50 min total time) | N/A | Use when patient unstable, worsening encephalopathy, or significant treatment changes |
| 99291 | Critical care, first 30–74 min | N/A | Applicable when physician spends ≥30 min in direct critical care for encephalopathy/delirium; document time |
| 99292 | Critical care, each additional 30 min | N/A | Add-on to 99291; document cumulative time |
| 99483 | Assessment of and care planning for a patient with cognitive impairment | N/A | Outpatient; comprehensive cognitive assessment ≥50 min; useful for post-discharge delirium follow-up or dementia workup; not used for acute inpatient care |
| 96116 | Neurobehavioral status exam, clinical assessment, first hour | 10 days | Formal neuropsychological testing by qualified provider; used for delirium vs. dementia differentiation |
| 96132 | Neuropsychological testing evaluation services, first hour | N/A | Psychologist-administered battery; useful post-acute to document cognitive sequelae |
| 96133 | Neuropsychological testing evaluation services, each additional hour | N/A | Add-on to 96132; document time |
| 70450 | CT scan of head, without contrast | N/A | Initial imaging to exclude hemorrhage, infarct, mass effect; first-line in acute AMS/encephalopathy |
| 70460 | CT scan of head, with contrast | N/A | With contrast enhancement; used for suspected abscess, meningitis, metastatic disease |
| 70470 | CT scan of head, without and with contrast | N/A | Combination study; highest diagnostic yield when structural lesion uncertain |
| 70551 | MRI brain, without contrast | N/A | Superior to CT for PRES (I67.4), Wernicke’s (E51.2), anoxic brain injury/encephalopathy (G93.1 when documented), and toxic encephalopathy; DWI sequences for anoxic injury |
| 70552 | MRI brain, with contrast | N/A | Used for inflammatory/autoimmune encephalopathy, meningeal enhancement, abscess |
| 70553 | MRI brain, without and with contrast | N/A | Complete evaluation including structural, enhancement, and diffusion imaging |
| 95816 | Electroencephalogram (EEG), awake and drowsy | N/A | Non-convulsive seizure/status epilepticus workup; diffuse slowing supports encephalopathy etiology |
| 95819 | EEG, awake and asleep | N/A | Extended EEG monitoring; preferred when seizure activity suspected |
| 62270 | Spinal puncture, lumbar, diagnostic | N/A | Lumbar puncture (LP) — used to exclude CNS infection, subarachnoid hemorrhage, autoimmune encephalitis; CSF opening pressure, cell count, culture, cytology, autoimmune panels |
🧾 HCPCS
The following HCPCS Level II codes are relevant to drug administration, monitoring, and supplies in encephalopathy and delirium management. All codes verified for CY2026 per CMS HCPCS 2026.
| HCPCS Code | Description | Typical Use / Notes |
|---|---|---|
| J3411 | Thiamine HCl, 100 mg injection | IV thiamine for Wernicke’s encephalopathy (E51.2). Critical to document Wernicke’s diagnosis; 500 mg TID = 5 units/dose. Often underutilized and underbilled. Report units accurately. |
| J2250 | Injection, midazolam HCl, per 1 mg | Benzodiazepine for alcohol withdrawal delirium (F10.231) / DTs. Symptom-triggered CIWA protocol. IV/IM. Not appropriate monotherapy for non-withdrawal delirium. |
| J0131 | Injection, acetaminophen, 10 mg (IV) | IV acetaminophen (Ofirmev) for pain management in encephalopathy patients to reduce opioid burden and minimize delirium risk in postoperative or ICU settings. |
| J1631 | Injection, haloperidol decanoate, per 50 mg | IM haloperidol for acute agitation/hyperactive delirium. Low-dose IV haloperidol (J1630 for lactate, per 5 mg) commonly used in ICU; Part B when administered in facility setting. |
| J3370 | Injection, vancomycin HCl, 500 mg | Antibiotic for sepsis/meningitis underlying metabolic encephalopathy; report with appropriate E/M and diagnosis codes; note for septic encephalopathy cases. |
| Part D: Lactulose | Lactulose solution (oral/enema) | Hepatic encephalopathy maintenance therapy (K72.xx). Prescription Part D benefit. Titrate to 2–3 soft bowel movements/day. Formulary varies by plan. |
| Part D: Haloperidol | Haloperidol tablets (oral) | Delirium prevention/treatment; outpatient/transition of care. Part D. Lowest effective dose; Black Box Warning for elderly patients with dementia. |
| Part D: Quetiapine | Quetiapine fumarate (Seroquel) | Off-label delirium management; Part D. Often preferred for hepatic encephalopathy patients with agitation; sedating at low doses. |
| Part D: Rifaximin | Rifaximin (Xifaxan) 550 mg tablets | Secondary prophylaxis for hepatic encephalopathy (K72.xx). Part D; prior authorization commonly required. Evidence base: NEJM 2010 RFHE trial. |
📚 AHA Coding Clinic
The following AHA Coding Clinic advisories are directly applicable to encephalopathy and delirium coding. Coders and CDI specialists should maintain awareness of these official guidance updates.
| Publication | Topic | Key Guidance |
|---|---|---|
| 2Q 2017 | Septic Encephalopathy | Coding Clinic, 2Q 2017, “Encephalopathy due to Sepsis”: assign G93.41, Metabolic encephalopathy, for encephalopathy due to sepsis (Index: Encephalopathy, septic; G93.41 inclusion term Septic encephalopathy). Sequence the sepsis code per Section I.C.1.d, with G93.41 as an additional diagnosis; when severe sepsis is present, R65.2- is also assigned and its use additional code note includes G93.41. |
| 4Q 2022 | Hepatic Encephalopathy, K76.82 | Coding Clinic, 4Q 2022, “Hepatic Encephalopathy”: hepatic encephalopathy without coma is assigned K76.82, Hepatic encephalopathy, effective October 1, 2022, with a code also note for the underlying liver disease (for example, K70.40, K72.10, K72.90). K76.82 has an Excludes1 note for hepatic failure with coma (K72.01, K72.11, K72.91) and alcoholic hepatic failure with coma (K70.41); assign those codes when coma is documented. Earlier advice (Coding Clinic, 2Q 2016) to assign K72.90 for hepatic encephalopathy is superseded by K76.82. |
| Centers for Medicare & Medicaid Services and National Center for Health Statistics. ICD-10-CM Tabular List of Diseases and Injuries FY 2027, code F05 | Delirium Superimposed on Dementia | Delirium superimposed on dementia is an inclusion term at F05, Delirium due to known physiological condition. F05 has a code first note for the underlying physiological condition, such as dementia (F03.9-); report the dementia code first, followed by F05. |
| 1Q 2017 | Toxic Encephalopathy, Adverse Effect Sequencing | Coding Clinic, 1Q 2017, “Toxic Encephalopathy due to Adverse Effect of Ciprofloxacin”, assigned G92, Toxic encephalopathy, followed by T36.8X5A for the adverse effect. G92 has since been subdivided: the FY 2027 Index entry Encephalopathy, due to drugs, directs to G92.8, Other toxic encephalopathy, which has a use additional code note for the adverse effect (T36-T50 with fifth or sixth character 5). Sequence G92.8 first, followed by the adverse effect code. |
| Centers for Medicare & Medicaid Services and National Center for Health Statistics. ICD-10-CM Index and Tabular List FY 2027, Encephalopathy, Wernicke’s; code G31.2 | Wernicke’s Encephalopathy and Thiamine Deficiency | Assign E51.2, Wernicke’s encephalopathy, when the provider documents Wernicke’s encephalopathy (Index: Encephalopathy, Wernicke’s). Code assignment is based on the provider’s diagnostic statement, not on whether specific clinical criteria such as the full triad are documented (Section I.A.19). G31.2, Degeneration of nervous system due to alcohol, includes alcoholic encephalopathy and has a code also note for the associated alcoholic disorder (F10.-). |
AHA Coding Clinic advisories represent the official interpretation of ICD-10-CM coding conventions and guidelines by the AHA Central Office. While not CMS law, they represent the standard of practice for hospital coding compliance and are recognized by CMS and MACs as the authoritative source for ICD-10-CM coding guidance. Facilities that deviate from Coding Clinic guidance face audit risk under RAC and MAC medical review programs.
💰 HCC / Risk Adjustment
Most encephalopathy and delirium codes do not map to a V28 payment HCC. Mappings below follow the 2024 CMS-HCC model (commonly called V28), which CMS uses at 100 percent for non-PACE Medicare Advantage risk scores and continued for CY 2027, and the CMS 2027 Initial ICD-10-CM Mappings. Coefficients vary by enrollee segment and payer, so this guide does not quote RAF weights; check the current CMS model software. Hierarchies are applied by CMS after coding: code every documented, supported condition.
| ICD-10-CM Code(s) | Description | V28 HCC | Coding / Documentation Notes |
|---|---|---|---|
| G93.40, G93.41, G92.8, G92.9, I67.4 | Encephalopathy, unspecified; metabolic; toxic; hypertensive encephalopathy | No V28 payment HCC | Still important for MS-DRG severity (CC/MCC) |
| F05 | Delirium due to known physiological condition | No V28 payment HCC | Code the underlying condition |
| G93.1 | Anoxic brain damage, NEC | HCC 202 — Coma, Brain Compression/Anoxic Damage | — |
| K76.82 | Hepatic encephalopathy | HCC 63 — Chronic Liver Failure/End-Stage Liver Disorders | — |
| F10.231 | Alcohol dependence with withdrawal delirium | HCC 136 — Alcohol Use with Psychotic Complications | — |
| F10.230, F10.239 | Alcohol dependence with withdrawal, uncomplicated or unspecified | HCC 139 | — |
| E51.2 | Wernicke’s encephalopathy | No V28 payment HCC | Code also alcohol use disorder when documented |
Sources: CMS 2027 Initial ICD-10-CM Mappings (2024 CMS-HCC model, V28); CMS CY 2024 Rate Announcement, Attachment VI (hierarchies, interactions); FY 2027 ICD-10-CM Tabular List, Index, and Official Guidelines. Verified November 3, 2026.
✍️ CDI Query Templates
The following compliant CDI query templates are designed per AHIMA Practice Brief: Guidance for Clinical Documentation Integrity Queries (2019) and ACDIS CDI best practices. All queries are non-leading, multiple-choice, and present clinically supported options without directing the provider to a specific coding-favorable answer.
| # | Query Scenario | Query Language / Template |
|---|---|---|
| 1 | AMS → Encephalopathy Clarification Patient admitted with “altered mental status” — metabolic derangements present (elevated BUN, sepsis, electrolyte disturbance) | “The patient was admitted with altered mental status. Clinical findings include [BUN 85 / sepsis / hyponatremia — select applicable]. Based on your clinical assessment, does the patient’s presentation represent: (a) Metabolic encephalopathy; (b) Toxic encephalopathy (medication/substance-related); (c) Delirium due to known physiological condition; (d) Altered mental status — etiology unclear at this time; (e) Other — please specify: ___. If encephalopathy is documented, please indicate the specific etiology in your progress note or final diagnosis.” |
| 2 | Septic Encephalopathy Confirmation Sepsis documented + neurological changes; physician notes “confusion” or “AMS” in assessments | “This patient has documented sepsis [A41.xx]. Clinical findings also include [confusion / somnolence / disorientation / GCS decline]. Does the documented neurological dysfunction represent: (a) Metabolic encephalopathy due to sepsis (septic encephalopathy); (b) Delirium due to sepsis (F05); (c) Altered mental status — etiology not further specified; (d) Another neurological condition — please specify: ___.” |
| 3 | Encephalopathy Etiology Specification “Encephalopathy” documented without specific type; multiple potential etiologies present | “The assessment includes ‘encephalopathy.’ To ensure accurate clinical documentation, could you clarify the primary etiology: (a) Metabolic encephalopathy (electrolyte, renal, respiratory cause); (b) Toxic encephalopathy (medication, drug, or chemical-related); (c) Anoxic/hypoxic-ischemic encephalopathy; (d) Hypertensive encephalopathy; (e) Hepatic encephalopathy (K76.82 when without coma; applicable hepatic failure with coma code when coma is documented; do not add G93.4x); (f) Wernicke’s encephalopathy (thiamine deficiency); (g) Other — please specify: ___. Your specification ensures the most accurate capture of the patient’s condition and severity.” |
| 4 | Delirium vs. Dementia Differentiation Patient with known cognitive impairment; acute behavioral changes documented; “sundowning” or “confusion” charted | “The patient has a history of [dementia / cognitive impairment] and is presenting with [new-onset confusion / agitation / behavioral changes]. Could you clarify whether this represents: (a) Acute delirium superimposed on pre-existing dementia (both F05 and dementia code apply); (b) Behavioral and psychological symptoms of dementia (BPSD) without superimposed delirium; (c) Progressive worsening of baseline dementia without acute delirium; (d) A new or different neurological condition — please specify: ___. Documentation of superimposed delirium requires both conditions to be coded and both affect clinical management.” |
| 5 | Hepatic Encephalopathy Staging / Acuity Known cirrhosis + altered mental status; liver failure coded without acuity specification | “The patient has documented liver failure/cirrhosis with altered mental status. Based on the West Haven Criteria for hepatic encephalopathy, does this patient’s presentation reflect: (a) Hepatic encephalopathy without coma (subclinical/Grade I–II: mild disorientation, behavioral changes, minimal asterixis); (b) Hepatic encephalopathy with coma (Grade III–IV: stupor, response to stimuli only, or full coma); (c) No hepatic encephalopathy — neurological symptoms attributable to other cause. Note: K72.x1 (‘with coma’) is coded when the patient meets coma criteria, capturing maximum severity.” |
| 6 | Wernicke’s Encephalopathy Confirmation Patient with alcohol use disorder, malnutrition, or NPO status; thiamine ordered; confusion/ataxia present | “This patient has [alcohol use disorder / prolonged NPO / malnutrition] and presents with [confusion / ataxia / ophthalmoplegia]. Thiamine has been/is being administered. Based on your clinical assessment, does this patient’s presentation meet criteria for: (a) Wernicke’s encephalopathy (thiamine deficiency — E51.2); (b) Alcoholic encephalopathy — chronic degeneration (G31.2); (c) Metabolic encephalopathy from another cause; (d) Delirium from alcohol withdrawal (F10.231); (e) Clinical features insufficient to diagnose Wernicke’s at this time.” |
| 7 | Medication-Induced vs. Metabolic Encephalopathy Polypharmacy patient with altered mental status; multiple potential contributing factors | “This patient has altered mental status with [elevated BUN/creatinine / high anticholinergic burden / recent opioid dose increase / antibiotic therapy] as potential contributing factors. Could you clarify the primary mechanism: (a) Toxic encephalopathy — primarily medication/drug-induced (G92.8 + T-code adverse effect); (b) Metabolic encephalopathy — primarily organ dysfunction/metabolic cause (G93.41); (c) Mixed toxic-metabolic encephalopathy — please specify the predominant cause; (d) Delirium due to physiological condition (F05) — underlying cause not further specified; (e) Altered mental status — etiology undetermined at this time. Distinguishing toxic from metabolic etiology impacts both coding specificity and clinical decision-making regarding medication management.” |
Alcohol withdrawal exists on a spectrum from mild (F10.230) to severe with delirium/DTs (F10.231). The delirium tremens code (F10.231) is an MCC and requires documented: (1) alcohol dependence, (2) withdrawal state, and (3) delirium. Review CIWA-Ar scores, nursing assessment documentation, and physician notes for autonomic instability (tachycardia, diaphoresis, hypertension) and cognitive changes. When these elements exist in the chart without an explicit “delirium tremens” or “F10.231-level” diagnosis, a concurrent CDI query to the treating physician is appropriate.
🧑⚕️ Treatments (Clinical)
Clinical treatment of encephalopathy and delirium is etiology-directed. The following represents evidence-based management principles per major clinical societies.
Universal Principles — Non-Pharmacological (First Line for Delirium): Per SCCM PADIS 2018 Guidelines and American College of Physicians, non-pharmacological multicomponent interventions are the most evidence-supported strategy for delirium prevention and treatment: early mobilization, reorientation (lighting, clocks, familiar objects), hearing and vision aids, sleep optimization, family engagement, hydration, early removal of indwelling catheters/restraints, and pain management.
Metabolic Encephalopathy (G93.41) — Treat the Underlying Cause:
- Septic encephalopathy: IV broad-spectrum antibiotics, source control, resuscitation per Surviving Sepsis Campaign Guidelines
- Uremic encephalopathy: Urgent dialysis (hemodialysis or CRRT); dietary protein restriction; thiamine supplementation
- Hypoglycemic encephalopathy: IV dextrose (D50W bolus) — emergent; document resolution after treatment
- Hypercapnic encephalopathy: Bronchodilators, NIV/BiPAP, high-flow O2 cautiously in COPD; intubation if refractory
- Electrolyte-related encephalopathy: Careful sodium correction (hyponatremia — ≤8 mEq/L/24h to prevent osmotic demyelination), calcium normalization, magnesium repletion
Hepatic Encephalopathy (K76.82 without coma; applicable hepatic failure with coma code when coma is documented): Per AASLD guidance: lactulose (first-line; titrate to 2–3 loose stools/day), rifaximin (secondary prophylaxis), dietary protein adjustment (do NOT restrict — 1.2–1.5 g/kg/day), zinc supplementation, treat precipitants (GI bleed, infection, dehydration, constipation). Liver transplantation evaluation for refractory cases.
Toxic Encephalopathy (G92.8) — Remove/Reverse the Toxin: Discontinue offending medication; supportive care; specific antidotes when available (naloxone for opioids, flumazenil caution in benzodiazepines, physostigmine for anticholinergic toxidrome in select cases). Activated charcoal if acute ingestion within 1–2 hours and airway protected.
Alcohol Withdrawal Delirium/DTs (F10.231): Symptom-triggered benzodiazepine protocol per CIWA-Ar score; IV lorazepam or diazepam preferred; IV thiamine before any dextrose-containing fluids; electrolyte repletion (magnesium, potassium, phosphate); seizure precautions; ICU monitoring for autonomic instability. Per NIAAA, mortality of untreated DTs is 5–15%; with appropriate treatment, <1%.
Wernicke’s Encephalopathy (E51.2): High-dose IV thiamine — 500 mg TID IV for 2–3 days (EFNS guidelines), then 250 mg/day for 5 days before transition to oral. Give BEFORE any glucose-containing solutions. MRI brain (DWI/FLAIR) for confirmation. Address malnutrition and alcohol use disorder concurrently.
Anoxic brain damage/HIE (G93.1 when documented): Targeted Temperature Management (TTM) at 33–36°C for 24 hours in comatose post-cardiac arrest patients per AHA/ILCOR 2023 Guidelines; prognostication multimodality assessment (EEG, SSEP, NSE, brain MRI) at 72+ hours; neuroprotective supportive care; rehabilitation referral for survivors.
Hypertensive Encephalopathy (I67.4): Emergent, controlled BP reduction — target 10–20% reduction in first hour using IV agents (labetalol, nicardipine, clevidipine); avoid rapid normalization; nitroprusside if needed but monitor cyanide toxicity. Per AHA Hypertension Guidelines, radiographic resolution of PRES expected with BP control.
🎓 Patient Education / Summary
The following patient-facing education points are intended for use by CDI specialists when counseling clinical teams on documentation that supports safe care transitions, and for discharge planning documentation that supports accurate coding and readmission risk reduction.
For Patients and Families — Key Messages:
- What it is: Encephalopathy means the brain is not working normally because of a problem elsewhere in the body — such as an infection, liver disease, kidney failure, medication reaction, or low oxygen. It is usually reversible when the underlying cause is treated.
- Delirium explained: Delirium is a sudden confusion that comes and goes — different from everyday forgetfulness. Signs include not knowing where you are, seeing things that aren’t there, or being very restless or unusually sleepy. It is common in hospitals, especially in older adults and ICU patients.
- Recovery: Most encephalopathy and delirium resolves over days to weeks once the cause is treated. Some patients have prolonged cognitive recovery. Older adults may take months to return to baseline. Follow up with your primary care provider for cognitive reassessment.
- Preventing recurrence: Avoid medications that increase delirium risk (anticholinergics, sleep aids, opioids when alternatives exist). Maintain regular sleep schedule. Stay mentally and physically active. Manage chronic conditions (liver disease, kidney disease, diabetes, hypertension) proactively.
- Alcohol use disorder: If alcohol withdrawal delirium (DTs) was part of the hospital course, this represents a serious and life-threatening complication of alcohol dependence. Referral to addiction medicine and treatment programs is strongly recommended. Resources: SAMHSA National Helpline 1-800-662-4357.
- Liver disease: If hepatic encephalopathy was the cause, strict medication adherence (lactulose, rifaximin), low-sodium diet, alcohol abstinence, and regular liver specialist follow-up are essential to prevent recurrence. Know the warning signs: increasing confusion, jaundice, abdominal swelling.
- For caregivers: Hospital delirium increases falls, aspiration risk, and functional decline. Caregiver reorientation, familiar objects, and maintaining normal daily rhythms during hospitalization reduce delirium duration. Advocate for early mobility and removal of unnecessary tubes/restraints.
Documentation Note for Clinical Teams: Accurate discharge documentation of encephalopathy type and etiology is essential not only for coding and reimbursement, but for care continuity. Post-acute facilities, home health agencies, and outpatient providers rely on the discharge diagnosis to plan appropriate follow-up, medication reconciliation, and monitoring intensity. A discharge summary that reads “metabolic encephalopathy due to sepsis, resolved” communicates far more clinical utility — and supports appropriate quality metrics — than “altered mental status, improved.”
About this Guide
This Clinical Documentation Guide is published by CCO Academy and is intended for credentialed coding, CDI, and clinical documentation professionals. Content is updated for FY2027 ICD-10-CM (effective October 1, 2026). All code assignments should be verified against the official ICD-10-CM Tabular List, AHA Coding Clinic, and applicable payer-specific policies. This guide does not constitute legal, medical, or compliance advice.
Last reviewed: October 2026 · Next scheduled review: April 2027
Ready to turn this knowledge into a credential?
These Clinical Documentation Guides are a free companion to CCO’s paid training programs. Browse our full CCO Course, Blitz & Practice Exam Catalog — every core course, review blitz, practice exam, textbook, and free resource in one place — and find the perfect next step for your coding career.
CCO Hero
Know someone starting a medical coding career?
Share your personal CCO link. Your friend saves 20% on their first course or practice exam of $100 or more, and you earn 5% cash on their first enrollment over $100.
Become a CCO Hero